InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,729.40
(
0.01%
)
US TECH 100
19,477.20
(
-0.10%
)
Dow Jones
41,932.26
(
-0.29%
)
Brent Oil
74.64
(
0.76%
)
Bitcoin
68,394.69
(
-0.49%
)
Post# of 144823
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

longboarder7892

Send PM Follow Ignore
Followers 23
Posts 2036
Boards Moderated 0
Alias Born 12/06/2017

longboarder7892

Re: None

Monday, 08/03/2020 11:06:39 AM

Monday, August 03, 2020 11:06:39 AM

Post# of 144823
What would it mean for our trial if Dr. Daniel Von Hoff was picked as the CMO funding would be coming our way for sure without a problem.
He was Dr.Hidalgo's mentor, teacher. and friend. What better doctor would fit?

Wouldnt it be something If Dr Daniel Von Hoff is the CMO that would really turn eyes onto our trial for sure. I would say he could be in the running for sure.
What a way for him to retire on his long great career.
Dr. Von Hoff is a pioneer and world leader in translational medicine, accelerating novel drug discoveries from the laboratory to cancer treatments in clinical trials. He has personally been involved in over 200 clinical trials. In 1985, when his NFCR grant support began, his research led to the first approved treatment for pancreatic cancer, the chemotherapy gemcitabine.



Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent PMCB News
More PMCB News
InvestorsHub NewsWire

FEATURED North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • Nov 4, 2024 9:00 AM

Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM

CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM

Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM

Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM

Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM

Start posting your company's news
Only $200 per official company press release!